Provided by Tiger Trade Technology Pte. Ltd.

Harmony Biosciences Holdings, Inc.

41.25
+1.874.75%
Post-market: 41.250.00000.00%16:01 EDT
Volume:831.32K
Turnover:33.90M
Market Cap:2.40B
PE:13.35
High:41.49
Open:39.38
Low:39.38
Close:39.38
52wk High:41.49
52wk Low:25.52
Shares:58.24M
Float Shares:50.80M
Volume Ratio:1.50
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.09
EPS(LYR):2.71
ROE:20.46%
ROA:11.62%
PB:2.40
PE(LYR):15.22

Loading ...

Harmony Biosciences spotlights Phase 3 HBS-301 narcolepsy, idiopathic hypersomnia studies at SLEEP 2026

Reuters
·
Jun 11

Harmony Biosciences to present six narcolepsy, idiopathic hypersomnia posters at SLEEP 2026 meeting

Reuters
·
Jun 11

Looking Back at Stock Picks Hyatt Hotels, Sensient Technologies, Harmony Biosciences. What the Charts Say. -- Barrons.com

Dow Jones
·
Jun 04

Harmony Biosciences to present at Goldman Sachs Global Healthcare Conference fireside chat

Reuters
·
May 27

Harmony Biosciences CFO Glenn Reicin files initial beneficial ownership statement

Reuters
·
May 19

Harmony Biosciences Shareholders Approve Governance Measures at Meeting

TIPRANKS
·
May 15

Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Maravai Lifesciences Holdings (MRVI) and Alkermes (ALKS)

TIPRANKS
·
May 11

Harmony Biosciences Is Maintained at Hold by Truist Securities

Dow Jones
·
May 09

Harmony Biosciences price target raised to $29 from $25 at Truist

TIPRANKS
·
May 08

Harmony Biosciences backs FY26 revenue view $1B-$1.04B, consensus $1.02B

TIPRANKS
·
May 07

Stock Track | Harmony Biosciences Plunges 5.43% in Pre-Market After Q1 Earnings Miss Estimates

Stock Track
·
May 07

GUIDANCE: (HRMY) Harmony Biosciences Expects 2026 WAKIX Net Revenue Range $1.0B - $1.04B

MT Newswires Live
·
May 07

Earnings Flash (HRMY) Harmony Biosciences Posts Q1 EPS $0.55, vs. FactSet Est of $0.69

MT Newswires Live
·
May 07

Harmony Biosciences Q1 revenue rises less than expected

Reuters
·
May 07

Harmony Biosciences Q1 Adj. EPS $0.55 Misses $0.69 Estimate, Sales $215.400M Miss $225.227M Estimate

Benzinga Earnings
·
May 07

BRIEF-Harmony Biosciences Q1 Net Income USD 32.488 Million

Reuters
·
May 07

Harmony Biosciences: on Track to Achieve >$1 Bln in Narcolepsy Net Sales in 2026

THOMSON REUTERS
·
May 07

Harmony Biosciences Q1 Gross Profit USD 170.875 Million

THOMSON REUTERS
·
May 07

Harmony Biosciences Q1 Product Revenue USD 215.387 Million VS. Ibes Estimate USD 225.2 Million

THOMSON REUTERS
·
May 07

Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities

THOMSON REUTERS
·
May 07